Informations:
Erreur:
ID
27909
Description
Safety and Tolerability Study of the Monoclonal Antibody CT-011 in Patients With Chronic Hepatitis C Genotype I Infection; ODM derived from: https://clinicaltrials.gov/show/NCT00962936
Lien
https://clinicaltrials.gov/show/NCT00962936
Mots-clés
Versions (1)
- 04/12/2017 04/12/2017 -
Détendeur de droits
See clinicaltrials.gov
Téléchargé le
4 décembre 2017
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY 4.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Eligibility Chronic Hepatitis C NCT00962936
Eligibility Chronic Hepatitis C NCT00962936
- StudyEvent: Eligibility
Similar models
Eligibility Chronic Hepatitis C NCT00962936
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Age
Item
1. patient is between 18 and 60 years of age, both genders.
boolean
C0001779 (UMLS CUI [1])
Hepatitis C infection Genotype 1 Biopsy
Item
2. biopsy proven infection with hepatitis c genotype 1.
boolean
C0019196 (UMLS CUI [1,1])
C3532919 (UMLS CUI [1,2])
C0005558 (UMLS CUI [1,3])
C3532919 (UMLS CUI [1,2])
C0005558 (UMLS CUI [1,3])
Hepatitis C antibody positive
Item
3. positive for anti-hcv.
boolean
C0281863 (UMLS CUI [1])
Chronic Hepatitis C Duration
Item
4. chronically infected for at least 3 months from diagnosis.
boolean
C0524910 (UMLS CUI [1,1])
C0449238 (UMLS CUI [1,2])
C0449238 (UMLS CUI [1,2])
ECOG performance status
Item
5. ecog performance status ≤ 1.
boolean
C1520224 (UMLS CUI [1])
Interferon | Ribavirin | Peginterferon | Ineligibility Therapeutic procedure Specified | Ineligibility Transplantation of liver
Item
6. previous therapy with interferon +/- ribavirin or peginterferon +/- ribavirin or ineligibility for this type of therapy or for liver transplantation.
boolean
C0021747 (UMLS CUI [1])
C0035525 (UMLS CUI [2])
C0982327 (UMLS CUI [3])
C1512714 (UMLS CUI [4,1])
C0087111 (UMLS CUI [4,2])
C0205369 (UMLS CUI [4,3])
C1512714 (UMLS CUI [5,1])
C0023911 (UMLS CUI [5,2])
C0035525 (UMLS CUI [2])
C0982327 (UMLS CUI [3])
C1512714 (UMLS CUI [4,1])
C0087111 (UMLS CUI [4,2])
C0205369 (UMLS CUI [4,3])
C1512714 (UMLS CUI [5,1])
C0023911 (UMLS CUI [5,2])
Antiviral Therapy
Item
1. patients who received any type of anti viral treatment during the 3 months prior to enrollment.
boolean
C0280274 (UMLS CUI [1])
Malignant Neoplasms
Item
2. any history or active malignancy.
boolean
C0006826 (UMLS CUI [1])
Organ Transplantation Major | Functional status of graft
Item
3. history of major organ transplantation with an existing functional graft.
boolean
C0029216 (UMLS CUI [1,1])
C0205164 (UMLS CUI [1,2])
C1717849 (UMLS CUI [2])
C0205164 (UMLS CUI [1,2])
C1717849 (UMLS CUI [2])
Systemic therapy
Item
4. patients who received any systemic concurrent therapy within the last 4 weeks.
boolean
C1515119 (UMLS CUI [1])
Patients Progressing to Acute Liver Failure
Item
5. patients progressing to acute liver failure (alf).
boolean
C0030705 (UMLS CUI [1,1])
C0205329 (UMLS CUI [1,2])
C0162557 (UMLS CUI [1,3])
C0205329 (UMLS CUI [1,2])
C0162557 (UMLS CUI [1,3])